Total Brain Ltd
ASX:TTB
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
AU |
Total Brain Ltd
ASX:TTB
|
267.4k AUD | -0.1 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
89B EUR | 12.8 | |
US |
Cigna Corp
NYSE:CI
|
95.7B USD | 12.7 | ||
US |
CVS Health Corp
NYSE:CVS
|
71.6B USD | 8.8 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.4B USD | 18.3 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
15.5B EUR | 16.4 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.9B USD | 15.1 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 15.5 | |
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.8B EUR | 15.6 | ||
US |
DaVita Inc
NYSE:DVA
|
12.2B USD | 12 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -21.5 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.